Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
You may qualify if you have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnea
A growing array of treatment modalities and new entrants are crowding the market, with biotech companies promoting next-generation GLP-1 candidates alongside established pharmaceutical players
A 2023 study found that GLP-1 weight-loss therapy was linked to a small but increased risk of serious GI events, including a higher risk of intestinal obstruction compared to other weight-loss drugs
doi: 10.1073/pnas.84.10.3434
US$ 24.14
US$ 22.56
US$ 21.52
US$ 21.35
US$ 24.25
US$ 25.84
US$ 20.92
US$ 25.64
US$ 24.12
US$ 27.06
